Migraine study unlocks secrets of placebo vs. real drug effects

NCT ID NCT07071506

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how the information given to patients about their treatment affects their response to migraine medication. Researchers will give 60 adults with chronic migraine four different treatment conditions in a random order and measure changes in headache intensity, number of headache days, and side effects. The goal is to improve how we evaluate preventive migraine treatments by separating the drug's effect from the placebo effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Headache headache disorder migraine disorder migraine without aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurology, Aarhus University Hospital

    RECRUITING

    Aarhus N, Denmark, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Psychology and Behavioral sciences, Aarhus BSS, Aarhus University

    RECRUITING

    Aarhus C, Denmark, 8000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••